Eupraxia Pharmaceuticals Inc. (EPRX)
(Delayed Data from NSDQ)
$6.65 USD
+0.69 (11.58%)
Updated Sep 22, 2025 03:59 PM ET
After-Market: $6.66 +0.01 (0.15%) 7:58 PM ET
4-Sell of 5 4
D Value F Growth B Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
EPRX 6.65 +0.69(11.58%)
Will EPRX be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for EPRX based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for EPRX
Eupraxia Pharmaceuticals (EPRX) Launches $70M Public Offering
Eupraxia Pharmaceuticals prices $70M share offering
Closing Bell Movers: ACM Research up 5% after joining S&P SmallCap 600
Closing Bell Movers: ACM Research up 5% after joining S&P SmallCap 600
Closing Bell Movers: ACM Research up 5% after joining S&P SmallCap 600